or Try an Advanced Search...

    Technical Analysis for NRBO - NeuroBo Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 3.37 -2.03% -0.07
    NRBO closed down 2.03 percent on Friday, April 19, 2024, on 15 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 10
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical NRBO trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish -2.03%
    Wide Bands Range Expansion -2.03%
    Gapped Up Strength -2.03%
    Oversold Stochastic Weakness -2.03%
    Wide Bands Range Expansion -2.60%
    Gapped Up Strength -2.60%
    Oversold Stochastic Weakness -2.60%
    Wide Bands Range Expansion -0.88%
    Older End-of-Day Signals for NRBO ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 5 hours ago
    60 Minute Opening Range Breakdown about 9 hours ago
    Down 3% about 9 hours ago
    Fell Below Previous Day's Low about 9 hours ago
    Down 2 % about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NRBO Chart by TradingView
    Basic chart:

    Profile

    Researches and develops disease-modifying therapies for neurodegenerative diseases
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Organ Systems Neuroscience Stem Cell Neurodegenerative Diseases Degenerative Disease Neurodegeneration Senescence

    Is NRBO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 12 NeuroBo Pharmaceuticals files for $150M mixed shelf
    Apr 1 NeuroBo Pharmaceuticals Completes Enrollment of Part 1 of Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
    Mar 28 NeuroBo Pharmaceuticals GAAP EPS of -$2.46
    Mar 28 NeuroBo Pharmaceuticals Reports Year End 2023 Financial Results and Provides Corporate Update
    Mar 13 NeuroBo Phase 2a study for MASH drug to proceed as planned
    Mar 13 NeuroBo Pharmaceuticals Receives Safety Review Committee Approval to Continue With Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
    Mar 4 NeuroBo Pharmaceuticals appoints Marshall Woodworth as CFO
    Mar 4 NeuroBo Pharmaceuticals Appoints Seasoned Life Science Executive Marshall Woodworth as Chief Financial Officer
    Feb 29 NeuroBo stock jumps 14% on weight-loss drug update
    Feb 29 NeuroBo Pharmaceuticals Receives First Site IRB Approval for Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
    See more NRBO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.7499
    52 Week Low 2.8888
    Average Volume 136,899
    200-Day Moving Average 4.01
    50-Day Moving Average 4.61
    20-Day Moving Average 3.83
    10-Day Moving Average 3.55
    Average True Range 0.31
    RSI (14) 31.97
    ADX 23.51
    +DI 14.84
    -DI 26.74
    Chandelier Exit (Long, 3 ATRs) 3.79
    Chandelier Exit (Short, 3 ATRs) 4.20
    Upper Bollinger Bands 4.53
    Lower Bollinger Band 3.14
    Percent B (%b) 0.16
    BandWidth 36.11
    MACD Line -0.33
    MACD Signal Line -0.31
    MACD Histogram -0.0148
    Fundamentals Value
    Market Cap 16.35 Million
    Num Shares 4.85 Million
    EPS -43.82
    Price-to-Earnings (P/E) Ratio -0.08
    Price-to-Sales 0.00
    Price-to-Book 1.03
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.72
    Resistance 3 (R3) 3.72 3.60 3.66
    Resistance 2 (R2) 3.60 3.52 3.60 3.64
    Resistance 1 (R1) 3.49 3.46 3.43 3.49 3.62
    Pivot Point 3.37 3.37 3.35 3.37 3.37
    Support 1 (S1) 3.26 3.29 3.20 3.26 3.12
    Support 2 (S2) 3.14 3.23 3.14 3.10
    Support 3 (S3) 3.03 3.14 3.08
    Support 4 (S4) 3.03